09.08.2018 • News

Former Long-time M+W Executive Gerald Schneider Joins CRB Group

Gerald Schneider joins CRB Group GmbH as managing director.
Gerald Schneider joins CRB Group GmbH as managing director.

Gerald Schneider, a long-time business leader at M+W Group, has joined US competitor CRB Group as managing director for European commercial operations.

Schneider (54), who had been with M+W Group for more than 20 years, served at the Stuttgart, Germany-based company’s Central Europe division as chief financial officer since 2005 and as managing director since 2015. He holds a track record of establishing and developing multiple new offices, successfully restructuring business units and integrating new teams. As CFO, he held responsibility for company commercial affairs and led an international team of 60 employees. 

At CRB Group, a provider of design and consulting solutions for the global life science industry, Schneider’s role will be to provide leadership for CRB’s European offices, working collaboratively with operational leaders and staff. He will hold ultimate responsibility for CRB’s European commercial operations and execute business support systems for legal services, business licensing, project and business contracts, project controls, human resources, finance and accounting.

“We are extremely excited to have Gerald join our team in Europe. Aside from being a great cultural fit with CRB, his broad experience in business operations outside of the United States will be a tremendous asset to our growing international operations,” Ryan Schroeder, CRB’s president, said.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read